The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB

Journal of Molecular Biology

Volumn 261, Issue 5, 1996, Pages 599-606

  Agostini, Isabelle ^a   Navarro, Jean Marc ^a   Rey, Françoise ^a   Bouhamdan, Mohamad ^a   Spire, Bruno ^a   Vigne, Robert ^a   Sire, Joséphine ^a  

^a INSERM   (France)

Author keywords

Basal transcription factor TFIIB; Human immunodeficiency virus type 1 (HIV 1); Protein protein interaction; Transactivation; Vpr open reading frame (Vpr)

Indexed keywords

CHIMERIC PROTEIN; DNA; DNA BINDING PROTEIN; GLUTATHIONE TRANSFERASE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN; VPR PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030572623     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0485     Document Type: Editorial

References (44)

1. Balliet, J. W., Kolsol, D. L., Eiger, G., Kim, F. M., McGann, K. A., Srinivasan, A. & Collman, R. (1994). Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu and nef: mutational analysis of a prinary HIV-1 isolate. Virology, 200, 623-631.
2. Barberis, A., Müller, C. W., Harrison, S. C. & Ptashn, R. (1993). Delineation of two functional regions of transcription factor TFIIB. Proc. Natl Acad. Sci. USA, 90, 5628-5632.
3. BouHamdan, M., Benichou, S., Rey, F., Navarro, J. M., Agostini I., Spire, B., Camonis, J., Slupphaug, G., Vigne, R., Benarous, R. & Sire, J. (1996). Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70, 697-704.
4. Carey, M., Lin, Y.-S., Green, M. & Ptashne, M. (1990). A mechanism for synergistic activation of mammalian gene by GAL4 derivatives. Nature, 345, 361-364.
5. Carruth, L. M., Hardwick, J. M., Morse, B. A. & Clements J. E. (1994). Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains. J. Virol. 68, 6137-6146.
6. Cohen, E. A., Terwilliger, E. F., Jalinoos, Y., Proulx, J., Sodroski, J. G. & Haseltine, W. A. (1990). Identification of HIV-1 Vpr product and function. J. Acquired Immun. Defic. Synd. 3, 11-18.
7. Connor, R., Chen, B. K., Choe, S. & Landau, N. R. (1995). Vpr is required for efficient replication of human immunodeficiency virus type 1 in mononuclear phagocytes. Virology, 206, 935-944.
8. Courey, A. J. & Tjian, R. (1988). Analysis of Spl in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell, 55, 887-898.
9. Cullen, B. R. (1991). Human immunodeficiency virus as a prototypic complex retrovirus. J. Virol. 65, 1053-1056.
10. Dedera, D., Hu, W., Vander Heyden, N. & Ratner, L. (1989). Viral protein R of human immunodeficiency virus type 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells. J. Virology, 63, 3205-3208.
11. Drapkin, R., Merino, A. & Reinberg, D. (1993). Regulation of RNA polymerase II transcription. Curr. Opin. Cell Biol. 5, 469-476.
12. Gibbs, J. S., Lackner, A. A., Lang, S. M., Simon, M. A., Sehgal, P. K., Daniel, M. D. & Desrosiers, R. C. (1995). Progression to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69, 2378-2383.
13. Goodrich, J. A., Hoey, T., Thut, C. J., Admon, A. & Tjian, R. (1993). Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell, 75, 519-530.
14. Gorman, C. M., Moffat, L. F. & Howard, B. F. (1982). Recombinant genomes which expresses chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2, 1044-1051.
15. Gruda, M. C., Zabolotny, J. M., Xiao, J. H., Davidson, I. & Alwine, J. C. (1993). Transcriptional activation by Simian Virus 40 large T antigen: interactions with multiple components of the transcriptional complex. Mol. Cell. Biol. 13, 961-969.
16. Hawley-Nelson, P., Ciccarone, V., Gebeyehu, G., Jessee, J. & Felgner, P. H. (1993). Lipofectamine reagent: a new, higher efficiency polycationic liposome transfection reagent. Focus, 15, 73-79.
17. cdc2 activity. J. Virol. 69, 6705-6711.
18. Heinzinger, N. K., Bukrinsky, M. I., Haggerty, S. A., Ragland, A. M., Kewalramani, V., Lee, M.-A., Gendelman, H. E., Ratner, L., Stevenson, M. & Emerman, M. (1994). The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl Acad. Sci. USA, 91, 7311-7315.
19. Jowett, J. B. M., Planelles, V., Poon, B., Shah, N. P., Chen, M. L. & Chen, I. S. Y. (1995). The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69, 6304-6313.
20. Lang, S. M., Weeger, M., Stahl-Henning, C., Coulibaly, C., Hunsmann, G., Muller-Hermelink, J., Fuchs, D., Wachter, H., Daniel, M. M., Desrosiers, R. C. & Flekenstein, B. (1993). Importance of Vpr for infection rhesus monkeys with simian immunodeficiency virus. J. Virol. 67, 902-912.
21. Lavallée, C., Yao, X. J., Ladha, A., Göttlinger, H., Haseltine, W. A. & Cohen, E. A. (1994). Requirement of the Pr55 gag precursor for incorporation of the Vpr product in human immunodeficiency virus type 1 viral particles. J. Virol. 68, 1926-1934.
22. Lee, W. S., Kao C. C., Bryant, G. O., Liu, X. & Berk, A. J. (1991). Adenovirus Era activation domain binds the basic repeat in the TATA box transcription factor. Cell, 67, 365-376.
23. Levy, D. N., Fernandez, L. S., Williams, W. V. & Weiner, D. B. (1993). Induction of cell differentiation by human immunodeficiency virus 1 Vpr. Cell, 72, 541-550.
24. Levy, D. N., Refaeli, Y., MacGregor, R. R. & Weiner, D. B. (1994). Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA, 91, 10873-10877.
25. Levy, D. N., Refaeli, Y. & Weiner, D. B. (1995). Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69, 1243-1252.
26. Lillie, J. W. & Green, M. R. (1989). Transcription activation by the adenovirus Ela protein. Nature, 338, 39-44.
27. Lin, Y. S., Maldonado, E., Reinberg, D. & Green, M. R. (1991). Binding of general transcription factor TFIIB to an acidic activating region. Nature, 353, 569-571.
28. Liu, F. & Green, M. R. (1990). A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell, 61, 1217-1224.
29. Lu, Y. L., Spearman, P. & Ratner, L. (1993). Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67, 6542-6550.
30. Ma, J. & Ptashne, M. (1987). A new class of yeast transcriptional activators. Cell, 51, 113-119.
31. Malik, S., Hisatake, K., Sumimoto, H., Horikoshi, M. & Roeder, R. G. (1991). Sequence of general transcription factor TFIIB and relationships to other initiation factors. Proc. Natl Acad. Sci. USA, 88, 9553-9557.
32. Nabel, G. J. (1993). The role of cellular transcription factors in the regulation of human immunodeficiency virus gene expression. In Molecular Biology of Human Retroviruses (Cullen, B. R., ed.), pp. 49-73, IRL/Oxford University Press, Oxford.
33. Ogawa, K., Shibata, R., Kiyomasu, T., Higuchi, I., Kishida, Y., Ishimoto, A. & Adachi, A. (1989). Mutational analysis of the human immunodeficiency virus vpr open reading frame. J. Virol. 63, 4110-4114.
34. Paxton, W., Connor, R. I. & Landau, N. L. (1993). Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of Gag mutational analysis. J. Virol. 67, 7229-7237.
35. Peden, K., Emerman, M. & Montagnier, L. (1991). Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1 LAI, HIV-1 MAL and HIV-1 ELI. Virology, 185, 661-672.
36. cdc2-cyclin B. J. Virol. 69, 6859-6864.
37. Rogel, M. E., Wu, L. I. & Emerman, M. (1995). The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69, 882-888.
38. Ruddell, A. (1995). Transcription regulatory elements of the avian retroviral long terminal repeat. Virology, 206, 1-7.
39. Sadowski, I., Ma, J., Triezenberg, S. & Ptashne, M. (1988). GAL4-VP16 is an unusually potent transcriptional activator. Nature, 335, 563-564.
40. Southgate, C. D. & Green, M. R. (1991). The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev. 5, 2496-2507.
41. Steger, G., Ham J., Lefebvre O. & Yaniv, M. (1995). The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. EMBO J. 14, 329-340.
42. Tiley, L. S., Brown, P. H., Le, S. Y., Maizel, J. V., Clements, J. E. & Cullen, B. R. (1990). Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc. Natl Acad. Sci. USA, 87, 7497-7501.
43. Wang, L., Mukherjee, S., Jia, F., Narayan, O. & Zhao, L. J. (1995). Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Spl and trans-activation of viral long terminal repeat. J. Biol. Chem. 270, 25564-25569.
44. Zhao, L.-J., Mukherjee, S. & Narayan, O. (1994). Biochemical mechanism of Hiv-1 VpR function: specific interaction with a cellular protein. J. Biol. Chem. 269, 15577-15582.